Nootropil piracetam

For treatment of: nervous system, tranquilizing, nootropic.

Nootropil nootropics

For the treatment of internal organs: nervous system, improved performance
Purpose: nervous system
Appointment: symptomatic treatment of intellectual and mnestic disorders in the absence of an established diagnosis of dementia, reducing the manifestations of cortical myoclonia
Indications for use: Symptomatic treatment of memory disorders, intellectual disabilities in the absence of a diagnosis of dementia. Nootropil has the ability to reduce the manifestations of cortical myoclonia in sensitive patients. To determine the sensitivity to piracetam in a particular case, a trial course of treatment can be performed.
Contraindications:
-hypersensitivity to piracetam or pyrrolidone derivatives, as well as other components of the drug;
-chorea;
-acute cerebrovascular accident (hemorrhagic stroke);
-end stage of chronic renal failure.
Composition:
1 coated tablet contains: active substance: piracetam - 800 mg; excipients: silicon dioxide (14.7 mg), magnesium stearate (2.0 mg), macrogol 6000 (20.00 mg), sodium croscarmellose (16.70 mg); opadray Y-1-7000 (25.6 mg)[titanium dioxide (E171) (8.00 mg), macrogol 400 (1.60 mg), hypromellose 2910 5sr (E464) (16.00 mg)], opadray OY-S-29019 (1.0 mg) [hypromellose 2910 50sr (0.95 mg), macrogol 6000 (0.05 mg)].
Manufacturer: UCB Pharma, S.A.